Current role
Daniel J. Lippis
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Daniel J. Lippis
Edwards Lifesciences Corp reported in an 8-K filed July 25, 2025 that Daniel J. Lippis was appointed Corporate Vice President responsible for Transcatheter Aortic Valve Replacement, effective September 1, 2025.
“In connection with Mr. Wood's departure, effective September 1, 2025, Daniel J. Lippis, the Company's current Corporate Vice President, Japan, Greater China and Asia Pacific, will serve as the Company's Corporate Vice President responsible for Transcatheter Aortic Valve Replacement.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Edwards Lifesciences Corp (EW)
SEC 8-K
Current2025-09-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Edwards Lifesciences Corp
Other people whose current roles at this company are on record from its filings.
- Bernard Zovighian CEO, Board Member
- Mr. Mussallem CEO
- Mr. Zovighian CEO
- Mr. Ullem CFO
- Scott Ullem CFO
- Theodora Mistras CFO
- Andrew M. Dahl Chief Accounting Officer
- Bernard J. Zovighian Board Member
- David T. Feinberg, M.D. Board Member
- David T. Feinberg, MD Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.